144 related articles for article (PubMed ID: 37946469)
1. Qiteng Xiaozhuo granules medicated serum inhibits excessive proliferation and promotes apoptosis of human glomerular mesangial cells by targeting fat mass and obesity associated proteins.
Xingxing Z; Tao L; Liangbing W; Junmei S; Jiarong G
J Tradit Chin Med; 2023 Oct; 43(6):1072-1080. PubMed ID: 37946469
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of FTO inhibits excessive proliferation and promotes the apoptosis of human glomerular mesangial cells by alleviating FOXO6 m6A modification via YTHDF3-dependent mechanisms.
Zhuang X; Liu T; Wei L; Gao J
Front Pharmacol; 2023; 14():1260300. PubMed ID: 37822879
[No Abstract] [Full Text] [Related]
3. RNA sequencing reveals the mechanism of FTO in inhibiting inflammation and excessive proliferation of lipopolysaccharide-induced human glomerular mesangial cells.
Zhuang X; Liu T; Wei L; Gao Y; Gao J
Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3835-3846. PubMed ID: 37358794
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic insights into Qiteng Xiaozhuo Granules' regulation of autophagy for chronic glomerulonephritis treatment: Serum pharmacochemistry, network pharmacology, and experimental validation.
Liu T; Zhuang XX; Tang YY; Gao YC; Gao JR
J Ethnopharmacol; 2024 Apr; 324():117819. PubMed ID: 38286158
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of FTO alleviates osteoarthritis by regulating the processing of miR-515-5p and the TLR4/MyD88/NF-κB axis.
Cai D; Zhang J; Yang J; Lv Q; Zhong C
Int Immunopharmacol; 2023 Jan; 114():109524. PubMed ID: 36538851
[TBL] [Abstract][Full Text] [Related]
6. Demethyltransferase FTO alpha-ketoglutarate dependent dioxygenase (FTO) regulates the proliferation, migration, invasion and tumor growth of prostate cancer by modulating the expression of melanocortin 4 receptor (MC4R).
Li S; Cao L
Bioengineered; 2022 Mar; 13(3):5598-5612. PubMed ID: 34787056
[TBL] [Abstract][Full Text] [Related]
7. FTO inhibits oxidative stress by mediating m6A demethylation of Nrf2 to alleviate cerebral ischemia/reperfusion injury.
Hou L; Li S; Li S; Wang R; Zhao M; Liu X
J Physiol Biochem; 2023 Feb; 79(1):133-146. PubMed ID: 36327034
[TBL] [Abstract][Full Text] [Related]
8. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
9. FTO-Dependent N
Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
[TBL] [Abstract][Full Text] [Related]
10. FTO accelerates ovarian cancer cell growth by promoting proliferation, inhibiting apoptosis, and activating autophagy.
Zhao L; Kong X; Zhong W; Wang Y; Li P
Pathol Res Pract; 2020 Sep; 216(9):153042. PubMed ID: 32825930
[TBL] [Abstract][Full Text] [Related]
11. Increased N6-methyladenosine causes infertility is associated with FTO expression.
Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B
J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212
[TBL] [Abstract][Full Text] [Related]
12. FGF2 Is Protective Towards Cisplatin-Induced KGN Cell Toxicity by Promoting FTO Expression and Autophagy.
Wang R; Wang L; Wang L; Cui Z; Cheng F; Wang W; Yang X
Front Endocrinol (Lausanne); 2022; 13():890623. PubMed ID: 35784556
[TBL] [Abstract][Full Text] [Related]
13. Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia.
Huang Y; Su R; Sheng Y; Dong L; Dong Z; Xu H; Ni T; Zhang ZS; Zhang T; Li C; Han L; Zhu Z; Lian F; Wei J; Deng Q; Wang Y; Wunderlich M; Gao Z; Pan G; Zhong D; Zhou H; Zhang N; Gan J; Jiang H; Mulloy JC; Qian Z; Chen J; Yang CG
Cancer Cell; 2019 Apr; 35(4):677-691.e10. PubMed ID: 30991027
[TBL] [Abstract][Full Text] [Related]
14. Meclofenamic acid promotes cisplatin-induced acute kidney injury by inhibiting fat mass and obesity-associated protein-mediated m
Zhou P; Wu M; Ye C; Xu Q; Wang L
J Biol Chem; 2019 Nov; 294(45):16908-16917. PubMed ID: 31578283
[TBL] [Abstract][Full Text] [Related]
15. Ligustrazine inhibits lipopolysaccharide-induced proliferation by affecting P27, Bcl-2 expression in rat mesangial cells.
Xue Y; Tie CR; Li J; Tian T; Li QX
Eur J Pharmacol; 2011 Aug; 665(1-3):8-12. PubMed ID: 21586279
[TBL] [Abstract][Full Text] [Related]
16. FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner.
Ji FH; Fu XH; Li GQ; He Q; Qiu XG
Front Endocrinol (Lausanne); 2022; 13():857765. PubMed ID: 35721711
[TBL] [Abstract][Full Text] [Related]
17. PRKAA1, stabilized by FTO in an m6A-YTHDF2-dependent manner, promotes cell proliferation and glycolysis of gastric cancer by regulating the redox balance.
Zhang Y; Zhou X; Cheng X; Hong X; Jiang X; Jing G; Chen K; Li Y
Neoplasma; 2022 Dec; 69(6):1338-1348. PubMed ID: 36305690
[TBL] [Abstract][Full Text] [Related]
18. N6-Methyladenosine Demethylase FTO (Fat Mass and Obesity-Associated Protein) as a Novel Mediator of Statin Effects in Human Endothelial Cells.
Mo W; Chen Z; Zhang X; Dai G; Ma D; Pan J; Zhang X; Wu G; Fan W
Arterioscler Thromb Vasc Biol; 2022 May; 42(5):644-658. PubMed ID: 35296150
[TBL] [Abstract][Full Text] [Related]
19. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
[TBL] [Abstract][Full Text] [Related]
20. HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K/AKT/mTOR signaling pathway.
Guo C; Chu H; Gong Z; Zhang B; Li C; Chen J; Huang L
Life Sci; 2021 Aug; 278():119522. PubMed ID: 33894267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
